KYPROLIS - 76075-101-01 - (carfilzomib)

Alphabetical Index


Drug Information of KYPROLIS

Product NDC: 76075-101
Proprietary Name: KYPROLIS
Non Proprietary Name: carfilzomib
Active Ingredient(s): 60    mg/30mL & nbsp;   carfilzomib
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of KYPROLIS

Product NDC: 76075-101
Labeler Name: Onyx Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202714
Marketing Category: NDA
Start Marketing Date: 20120720

Package Information of KYPROLIS

Package NDC: 76075-101-01
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (76075-101-01) > 30 mL in 1 VIAL, SINGLE-USE

NDC Information of KYPROLIS

NDC Code 76075-101-01
Proprietary Name KYPROLIS
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (76075-101-01) > 30 mL in 1 VIAL, SINGLE-USE
Product NDC 76075-101
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name carfilzomib
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20120720
Marketing Category Name NDA
Labeler Name Onyx Pharmaceuticals, Inc.
Substance Name CARFILZOMIB
Strength Number 60
Strength Unit mg/30mL
Pharmaceutical Classes Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA]

Complete Information of KYPROLIS


General Information